The Effect of Nedocromil Sodium on Human Eosinophil Activation
- 5 Downloads
Nedocromil sodium inhibited the increase in eosinophil activation (measured by IgG- and complement-dependent cytotoxicity assays) induced by platelet activating factor (PAF). Inhibition of the upregulation in eosinophil effector function by nedocromil sodium was dose-dependent (optimal at 10− 7 mol/L) and paralleled that produced by a specific PAF antagonist, BN 52021. In addition, preliminary data suggest that nedocromil sodium can inhibit the increase in IgG-dependent release of LTC4 from human eosinophils after stimulation with the synthetic tripeptide, formyl-methionyl-leucyl-phenylalanine (fMLP). These data support our previous hypothesis that part of the mode of action of nedocromil sodium may be due to its ability to directly block the chemotactic factor-induced enhancement of inflammatory cell activity.
KeywordsPlatelet Activate Factor Cromoglycate Sodium Cromoglycate Schistosoma Mansoni Nedocromil Sodium
Unable to display preview. Download preview PDF.
- Anwar ARE, McKean JR, Smithers SR, Kay AB. Human eosinophil- and neutrophil-mediated killing of schistosomula of Schistosoma mansoni in vitro. 1. Enhancement of complement-dependent damage by mast cell-derived mediators and formyl methionyl peptides. Journal of Immunology 124: 1122–1129, 1980Google Scholar
- Kurihara K, Wardlaw AJ, Moqbel R, Kay AB. Inhibition of platelet activating factor (PAF)-induced chemotaxis, and PAF binding to human eosinophils and neutrophils by the specific gingkolide-derived PAF antagonist, BN 52021. Journal of Allergy and Clinical Immunology, in press Moqbel R, Sass-Kuhn SP, Goetzl EJ, Kay AB. Enhancement of neutrophil- and eosinophil-mediated complement-dependent killing of schistosomula of Schistosoma mansoni in vitro by leukotriene B4. Clinical and Experimental Immunology 52: 519–527, 1983Google Scholar